大会首页
关于大会
同期活动
演讲嘉宾
历届回顾
参展申请
展商中心
场馆介绍
联系我们
 
 
演讲嘉宾
 
胡静珊博士

Dr. Jing-Shan Hu received her BS degree in Biochemistry from Peking Univ., PhD degree from Univ. of Texas Graduate School of Biomedical Sciences at MD Anderson Cancer Center via CUSBEA program, and post-doctoral training at Harvard Medical School & Massachusetts General Hospital. She joined Human Genome Sciences in 1993 as one of the earliest scientists and was Project Leader of VEGF-2 Protein Therapeutics program collaborating with Tufts & Harvard Univ. VEGF-2 was eventually licensed to Boston Scientific Corp & Corautus Genetics for Phase II/III clinical trials.  She subsequently joined Affymetrix working in various capacities, including as Program Manager of toxicology/Pharmacogenomics, collaborating with Stanford Univ., Rockefeller Univ., and pharma industry to use GeneChip technology in drug discovery and development.  From 2004 to Jan, 2008, she worked at Roche Palo Alto as Head of Functional Biology, following serving as the program head for Toxicogenomics.  She had been with Merck & Co., Inc/MSD from Jan 2008 to Sept 2011, responsible for identifying, evaluating, and developing opportunities from Greater China for licensing, partnership, and acquisition of novel drug candidates and technologies for the company’s global interests.  Since Oct 2011, she has joined Bayer Healthcare as Vice President and Head of Innovation Center China of Global Drug Discovery, responsible for building partnerships with both academia and companies in China, as well as identifying and developing opportunities for early stage in/out-licensing.  Dr. Hu has 19 years of experience in research, management, partnership, licensing, and business development with US and German pharmaceutical/biotech companies.

第八届国际生物医药产业发展创新论坛